Haruya Okamoto

1PUBLICATIONS
2CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 25, 2022
The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.

Reiko Isa, Mano Horinaka, Taku Tsukamoto

Pageof 1